Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now has funded $29,495,835 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 194 grants at over 100 hospitals in 29 countries.

Note: All Grants Are U.S. Funded Through 2018

Murdoch Children's Research Institute – $100,000 USD / $156,914 AUD

Amount
$100,000.00 USD
Date
December 2024

Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of Diffuse Midline Gliomas

Grant Information

Children’s Cancer Institute – $70,400 USD / $110,467 AUD

Amount
$70,400.00 USD
Date
December 2024

A Novel Formulation to Allow the Simultaneous Targeting of MYC Expression and Copper Chelation to Treat DIPG Tumor and Overcome Multidrug Resistance

Grant Information

The Institute for Medical Research Israel-Canada – $40,000 USD / 143,580 INS

Amount
$40,000.00 USD
Date
December 2024

CXCR1/2 Signaling Pathway: A Role in the Invasive Mechanism of DIPG

Grant Information

Children's Healthcare of Atlanta – $100,000

Amount
$100,000.00 USD
Date
November 2024

Radiation Resistance in Medulloblastoma

Grant Information

University of Texas Health Science Center at San Antonio – $100,000

Amount
$100,000.00 USD
Date
November 2024

Targeting Metabolic Vulnerabilities for Treating Medulloblastoma

Grant Information

University of Texas Health Science Center at San Antonio – $50,000

Amount
$50,000.00 USD
Date
November 2024

Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma

Grant Information

Children’s National Medical Center – $300,000

Amount
$300,000.00 USD
Date
November 2024

Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.

Grant Information

Children's Hospital Los Angeles – $100,000

Amount
$100,000.00 USD
Date
October 2024

Targeting FOXR2 in Diffuse Midline Gliomas

Grant Information

University Hospital of Navarra - $100,000 USD, €92,637 EUR

Amount
$100,000.00 USD
Date
October 2024

Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.

Grant Information

The Institute of Cancer Research – $111,445 USD / £85,976 GBP

Amount
$111,445.00 USD
Date
October 2024

Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.

Grant Information

Children’s Cancer Institute – $100,000 USD / $150,589 AUD

Amount
$100,000.00 USD
Date
October 2024

Targeting lactate production pathways as a novel therapy against DIPG

Grant Information

Sydney Children's Hospital - Randwick – $196,577 USD / $296,025.11 AUD

Amount
$196,577.00 USD
Date
October 2024

Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas.

Grant Information

McGill University - $100,000

Amount
$100,000.00 USD
Date
October 2024

Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.

Grant Information

Cincinnati Children’s Hospital Medical Center - $200,000

Amount
$200,000.00 USD
Date
October 2024

Combining FLASH and immunotherapy to target medulloblastoma relapse

Grant Information

Emory University / Cincinnati Children's Hospital – $93,250

Amount
$93,250.00 USD
Date
March 2024

SUMOylation as a novel therapeutic target in DIPG

Grant Information